Fidelity Investments’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-18,194
| Closed | -$27K | – | 5628 |
|
|
2022
Q2 | $27K | Sell |
18,194
-2,605,438
| -99% | -$1.91M | ﹤0.01% | 3790 |
|
|
2022
Q1 | $3.02M | Buy |
2,623,632
+1,758,259
| +203% | +$2.87M | ﹤0.01% | 2494 |
|
|
2021
Q4 | $2.16M | Sell |
865,373
-934,744
| -52% | -$3.67M | ﹤0.01% | 2547 |
|
|
2021
Q3 | $9.22M | Sell |
1,800,117
-3,261
| -0.2% | -$19.8K | ﹤0.01% | 2162 |
|
|
2021
Q2 | $15M | Sell |
1,803,378
-4,701
| -0.3% | -$39.6K | ﹤0.01% | 1952 |
|
|
2021
Q1 | $15.7M | Buy |
1,808,079
+146,407
| +9% | +$1.51M | ﹤0.01% | 1879 |
|
|
2020
Q4 | $18M | Sell |
1,661,672
-348,891
| -17% | -$4.3M | ﹤0.01% | 1756 |
|
|
2020
Q3 | $24M | Sell |
2,010,563
-3,223
| -0.2% | -$43.2K | ﹤0.01% | 1491 |
|
|
2020
Q2 | $32.3M | Sell |
2,013,786
-1,728
| -0.1% | -$30.2K | ﹤0.01% | 1344 |
|
|
2020
Q1 | $31.3M | Sell |
2,015,514
-219,808
| -10% | -$4.72M | ﹤0.01% | 1224 |
|
|
2019
Q4 | $55M | Sell |
2,235,322
-429,490
| -16% | -$6.38M | 0.01% | 1164 |
|
|
2019
Q3 | $27.5M | Sell |
2,664,812
-540,601
| -17% | -$6.82M | ﹤0.01% | 1449 |
|
|
2019
Q2 | $40.2M | Sell |
3,205,413
-278,724
| -8% | -$3.59M | ﹤0.01% | 1326 |
|
|
2019
Q1 | $43.2M | Buy |
3,484,137
+11,759
| +0.3% | +$131K | 0.01% | 1273 |
|
|
2018
Q4 | $21.4M | Sell |
3,472,378
-193,825
| -5% | -$1.48M | ﹤0.01% | 1526 |
|
|
2018
Q3 | $38.9M | Sell |
3,666,203
-2,431,010
| -40% | -$27.7M | ﹤0.01% | 1390 |
|
|
2018
Q2 | $82.6M | Sell |
6,097,213
-1,328,126
| -18% | -$20.7M | 0.01% | 1037 |
|
|
2018
Q1 | $132M | Sell |
7,425,339
-105,855
| -1% | -$1.79M | 0.02% | 863 |
|
|
2017
Q4 | $94.5M | Sell |
7,531,194
-2,636,624
| -26% | -$38.3M | 0.01% | 1022 |
|
|
2017
Q3 | $194M | Buy |
10,167,818
+4,494,946
| +79% | +$68.6M | 0.02% | 701 |
|
|
2017
Q2 | $85.7M | Sell |
5,672,872
-1,317,587
| -19% | -$19.9M | 0.01% | 1056 |
|
|
2017
Q1 | $120M | Sell |
6,990,459
-1,175,788
| -14% | -$15.7M | 0.02% | 913 |
|
|
2016
Q4 | $98.8M | Hold |
8,166,247
| – | – | 0.01% | 993 |
|
|
2016
Q3 | $80.4M | Hold |
8,166,247
| – | – | 0.01% | 1079 |
|
|
2016
Q2 | $83.6M | Buy |
8,166,247
+308,014
| +4% | +$3.43M | 0.01% | 1063 |
|
|
2016
Q1 | $95.2M | Buy |
7,858,233
+1,677,533
| +27% | +$17M | 0.01% | 987 |
|
|
2015
Q4 | $99M | Hold |
6,180,700
| – | – | 0.01% | 977 |
|
|
2015
Q3 | $79.5M | Hold |
6,180,700
| – | – | 0.01% | 1059 |
|
|
2015
Q2 | $148M | Buy |
6,180,700
+814,261
| +15% | +$15.7M | 0.02% | 843 |
|
|
2015
Q1 | $101M | Buy |
5,366,439
+974,693
| +22% | +$20.1M | 0.01% | 1025 |
|
|
2014
Q4 | $82.9M | Buy |
4,391,746
+32,015
| +0.7% | +$748K | 0.01% | 1102 |
|
|
2014
Q3 | $118M | Buy |
4,359,731
+459,800
| +12% | +$14.3M | 0.02% | 891 |
|
|
2014
Q2 | $121M | Buy |
3,899,931
+149,822
| +4% | +$3.53M | 0.02% | 895 |
|
|
2014
Q1 | $85.4M | Buy |
3,750,109
+1,753,226
| +88% | +$53.1M | 0.01% | 1066 |
|
|
2013
Q4 | $41.5M | Buy |
1,996,883
+846,400
| +74% | +$24.5M | 0.01% | 1408 |
|
|
2013
Q3 | $46.2M | Hold |
1,150,483
| – | – | 0.01% | 1320 |
|
|
2013
Q2 | $32.4M | Buy |
+1,150,483
| New | +$29.6M | 0.01% | 1449 |
|
Other funds holding EPZM
Fidelity Investments's EPZM Position: Q3 2022 in Review
Fidelity Investments sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 18,194 shares — an estimated $27K sold.
Fidelity Investments first reported a position in EPZM in Q2 2013 and held it in 37 quarters. The position peaked at $194M in Q3 2017. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.
- Fidelity Investments reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
- Fidelity Investments sold 18,194 Epizyme, Inc shares in Q3 2022, an estimated $27K.
- Fidelity Investments first reported a position in Epizyme, Inc in Q2 2013 and held it in 37 quarters.
- Fidelity Investments's Epizyme, Inc position peaked at $194M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.
Based on Fidelity Investments's 13F filing for Q3 2022, filed 10 Nov 2022.